Multi-criteria optimization achieves superior normal tissue sparing in a planning study of intensity-modulated radiation therapy for RTOG 1308-eligible non-small cell lung cancer patients

作者：Kamran Sophia C; Mueller Birgit S; Paetzold Peter; Dunlap Joseph; Niemierko Andrzej; Bortfeld Thomas; Willers Henning; Craft David

来源：Radiotherapy and Oncology, 2016, 118(3): 515-520.

DOI：10.1016/j.radonc.2015.12.028

• Intensity-modulated radiation therapy
• Multi-criteria optimization
• Non-small cell lung cancer

Purpose: In this planning study, we studied the benefit of intensity-modulated radiation therapy (IMRT) with multi-criteria optimization (MCO) in locally advanced non-small cell lung carcinoma (NSCLC).
Methods: We selected 10 consecutive patients with gross tumor within 1 cm of the esophagus eligible for RTOG 1308, randomized phase II trial of 70 Gy protons vs photons. Planning was performed per protocol. In addition, a novel approach for esophagus sparing was applied by making the contralateral esophagus (CE) an avoidance structure. MCO and non-MCO plans underwent double-blinded review. Plan differences in dose-volume histogram parameters were analyzed.
Results: Median plan differences were mean lung dose = 0.8 Gy (p = 0.01), lung V20 = 1.1% (p = 0.06), heart V30 = 1.0% (p = 0.03), heart V45 = 0.6% (p = 0.03), esophagus V60 = 1.2% (p = 0.04), and CE V45 = 3.2% (p = 0.01), all favoring MCO over non-MCO. PTV coverage with 95% dose was >= 98.0% for both plans. There were 5 minor protocol deviations with non-MCO plans and 2 with MCO. Median improvement of active planning time with MCO was 88 min (p < 0.01). Physicians preferred 8 MCO and 2 non-MCO plans (p = 0.04).
Conclusions: MCO plans yielded significant improvements in organ-at-risk sparing without compromising target coverage, consumed less dosimetrist time, and were preferred by physicians. We suggest incorporating MCO into prospective clinical trials.

• 出版日期2016-3